BINDING OF [^99mTc]CHONDROITIN SULFATE TO SCAVENGER RECEPTORS ON HUMAN CHONDROCYTES AS COMPARED TO BINDING OF OXIDIZED [¹²⁵I]LDL ON HUMAN MACROPHAGES

REFERENCES

• Endemann G., Stanton L., Madden K., Bryant K., White R. T., Protter A. CD36 is a Receptor for Oxidized Low Density Lipoprotein. J. Biol. Chem. 1993; 268: 4569–4572
   PubMed Web of Science ®Google Scholar
• Nicholson A. S., Pearce F. A., Silverstein R. Oxidized LDL Binds to CD36 on Human Monocyte-Derived Macrophages and Transfected Cell Lines. Evidence Implicated the Lipid Moiety of the Lipoprotein as the Binding Site. Atheroscler. Thromb. Vasc. Biol. 1995; 15: 269–275
   PubMed Web of Science ®Google Scholar
• Witztum J. L., Steinberg D. Role of Oxidized Low Density Lipoprotein in Atherogenesis. J. Clin. Invest. 1991; 88: 1785–1792
   PubMed Web of Science ®Google Scholar
• Ross R. The Pathogenesis of Atherosclerosis: A Perspective for the 1990s. Nature 1993; 362: 801–808
   PubMed Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L. A Receptor-Mediated Pathway for Cholesterol Homeostasis. Science 1986; 232: 34–47
   PubMed Web of Science ®Google Scholar
• Steinberg D., Parthasarathy S., Carew T. E., Ho Y. K., Witztum J. L. Beyond Cholesterol: Modification that Increases its Atherogenicity. New Engl. J. Med. 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Henriksen T., Mahony E. M., Steinberg D. Enhanced Macrophage Degradation of Biologically Modified Low-Density Lipoprotein. Arteriosclerosis 1983; 3: 149–159
   PubMedGoogle Scholar
• Tontonoz P., Nagy L. Regulation of Macrophage Gene Expression by Peroxisome-Proliferator-Activated Receptor Gamma: Implications for Cardiovascular Disease. Curr. Opin. Lipidol. 1999; 10: 485–490
   PubMed Web of Science ®Google Scholar
• Tontonoz P., Nagy L., Alvarez J. G., Thomazy V. A., Evans R. M. PPAR Gamma Promotes Monocyte-Macrophage Differentiation and Uptake of Oxidized LDL. Cell 1998; 93: 241–252
   PubMed Web of Science ®Google Scholar
• Bassleer C. T., Combal J.P. A., Bougaret S., Malaise M. Effects of Chondroitin Sulfate and Interleukin-1β on Human Articular Chondrocytes Cultivated in Clusters. Osteoarthr. Cartilage 1998; 6: 196–204
   PubMed Web of Science ®Google Scholar
• Havel R. J., Eder H. A., Bragdon J. H. The Distribution and Chemical Composition of Ultracentrifugally Separated Lipoproteins in Human Serum. J. Clin. Invest. 1985; 34: 1345–1353
   Web of Science ®Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous Monitoring of In Vitro Oxidation of Human Low-Density Lipoproteins. Free Rad. Res Comm. 1981; 6: 67–75
   Google Scholar
• Buege J. A., Aust S. D. Lactoperoxidase-Catalyzed Lipid Peroxidation of Microsomal and Artificial Membranes. Biochim. Biophys. Acta 1976; 444: 192–201
   PubMed Web of Science ®Google Scholar
• Mc Conahey P. J., Dixon F. J. A Method of Trace Iodination of Proteins for Immunologic Studies. Int. Arch. Allergy 1966; 29: 185–187
   Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L. Lipoprotein Metabolism in the Macrophage: Implications for Cholesterol Deposition in Atherosclerosis. Annu. Rev. Biochem. 1983; 52: 223–261
   PubMed Web of Science ®Google Scholar
• Freeman M., Ekkel Y., Rohrer L., Penman M., Freedman N. J., Chisolm G. M., Krieger M. Expression of Type I and Type II Bovine Scavenger Receptors in Chinese Hamster Ovary Cells. Proc. Natl. Acad. Sci. USA 1991; 88: 4931–4935
   PubMed Web of Science ®Google Scholar
• Krieger M., Hertz J. Structures and Functions of Multiligand Lipoprotein Receptors: Macrophage Scavenger Receptors and LDL Receptor-Related Protein (LRP). Annu. Rev. Biochem. 1994; 63: 601–637
   PubMed Web of Science ®Google Scholar
• Sparrow C. P., Parthasarathy S., Steinberg D. A Macrophage Receptor that Recognizes Oxidized Low-Density Lipoprotein but not Acetylated Low-Density Lipoprotein. J. Biol. Chem. 1989; 264: 2599–2604
   PubMed Web of Science ®Google Scholar
• Camejo G., Rosengren B., Olson U., Lopez F., Olofson S. O., Westerlund C., Bondjers G. Molecular Basis of the Association of Arterial Proteoglycans with Low Density Lipoproteins: Its Effect on the Structure of the Lipoprotein Particle. Eur. Heart J. 1990; 11(Suppl. E)164–173
   PubMed Web of Science ®Google Scholar
• Arai H., Kita T., Yokode M., Narumiya S., Kawai C. Multiple Receptors for Modified Low-Density Lipoprotein in Mouse Peritoneal Macrophages: Different Uptake Mechanism for Acetylated and Oxidized Low-Density Lipoprotein. Biochem. Biophys. Res. Commun. 1989; 150: 1375–1382
   Google Scholar
• Van Berkel T.J. C., de Rijke Y. B., Kruijt K. Different Fate In Vivo of Oxidatively Modified Low-Density Lipoprotein and Acetylated Low-Density Lipoprotein in Rats.: Recognition by Various Scavenger Receptors on Kupfer and Endothelial Liver Cells. J. Biol. Chem. 1991; 266: 2282–2289
   PubMed Web of Science ®Google Scholar
• Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding Site on Macrophages that Mediates Uptake and Degradation of Acetylated Low Density Lipoprotein, Producing Massive Cholesterol Deposition. Proc. Natl. Acad. Sci. USA 1979; 76: 333–337
   PubMed Web of Science ®Google Scholar
• Bordji K., Grillasca J. P., Gouze J. N., Magdalou J., Schohn H., Keller J. M., Bianchi A., Dauca M., Netter P., Terlain B. Evidence for the Presence of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma and Retinoid Z Receptor in Cartilage. PPARgamma Activation Modulates the Effects of Interleukin-1Beta on Rat Chondrocytes. J. Biol. Chem. 2000; 275: 12243–12250
   PubMed Web of Science ®Google Scholar
• Fahmi H., Di Battista J. A., Pelletier J. P., Mineau F., Ranger P., Martel-Pelletier J. Peroxisome Proliferator–Activated Receptor Gamma Activators Inhibit Interleukin-1Beta-Induced Nitric Oxide and Matrix Metalloproteinase 13 Production in Human Chondrocytes. Arthritis Rheum. 2001; 44: 595–607
   PubMed Web of Science ®Google Scholar
• Ishihara M., Fedarko N. S., Conrad H. E. Involvement of Phosphatidylinositol and Insulin in the Coordinate Regulation of Proteoheparan Sulfate Metabolism and Hepatocyte Growth. J. Biol. Chem. 1987; 262: 4708–4716
   PubMed Web of Science ®Google Scholar
• Palmieri L., Conte A., Giovannini L., Lualdi P., Ronca G. Metabolic Fate of Exogenous Chondroitin Sulfate in the Experimental Animal. Arzneimittel Forsch. Drug Res. 1990; 40: 319–323
   PubMed Web of Science ®Google Scholar
• Staprans I., Felts J. M. Isolation and Characterization of Glycosaminoglycans in Human Plasma. J. Clin. Invest. 1985; 76: 1984–1991
   PubMed Web of Science ®Google Scholar
• Kaplan M., Aviram M. Macrophage Plasma Membrane Chondroitin Sulfate Proteoglycan Binds Oxidized Low-Density Lipoprotein. Atherosclerosis 2000; 149: 5–17
   PubMed Web of Science ®Google Scholar
• Camejo G., Rosengren B., Olson U., Lopez F., Olofson S. O., Westerlund C., Bondjers G. Molecular Basis of the Association of Arterial Proteoglycans with Low Density Lipoproteins. Its Effect on The Structure of the Lipoprotein Particle. Eur. Heart J. 1990; 11(Suppl. E)164–173
   PubMed Web of Science ®Google Scholar
• Ronca F., Palmieri L., Pinicucci P., Ronca G. Anti-Inflammatory Activity of Chondroitin Sulfate. Osteoarthr Cartilage 1998; 6S A: 14–21
   Google Scholar
• Pfander D., Cramer T., Deuerling D., Weseloh G., Swoboda B. Expression of Thrombospondin-1 and its Receptor CD36 in Human Osteoarthritic Cartilage. Ann. Rheum. Dis. 2000; 59: 448–454
   PubMed Web of Science ®Google Scholar
• Vijayagopal P., Srinivasan S. R., Radhakrishnamurthy B., Berenson G. S. Human Monocyte-Derived Macrophages Bind Low-Density-Lipoprotein-Proteoglycan Complexes by a Receptor Different from the Low-Density-Lipoprotein Receptor. Biochem. J. 1993; 289: 837–844
   PubMed Web of Science ®Google Scholar
• Kaplan M., Williams K. J., Mandel H., Aviram M. Role of Macrophage Glycosaminoglycans in the Cellular Catabolism of Oxidized LDL by Macrophages. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 542–553
   PubMed Web of Science ®Google Scholar